Overview
- The company, formerly Helius Medical Technologies, disclosed holdings of more than 2.2 million SOL plus over $15 million in cash, valuing combined assets above $525 million at $232.50 per SOL.
- The total now exceeds the gross proceeds from its September 18 private placement, a milestone the company says it achieved in under three weeks.
- Executives describe a MicroStrategy-style accumulation strategy focused on Solana, with plans to stake tokens for an estimated native yield of about 7%.
- Leadership reports rising institutional interest, highlighting momentum from Asia following recent regional digital asset conferences.
- Shares closed up about 7.7% at $17.49 following the update, and market reports characterize the position as among the largest SOL treasuries held by a non-crypto-native public company.